Spain under new pressure to back embryo work:
This article was originally published in Clinica
The Spanish government has come under renewed pressure to allow embryonic stem cell research. James Shapiro, of the Center for Clinical Islet Transplantation, at the University of Alberta, in Edmonton, Canada, has joined the debate, praising the work being led by Bernat Soria, director of the bioengineering institute of the Miguel Hernandez university, in Elche, Spain, into the synthesis of pancreatic beta cells, responsible for producing insulin. Dr Shapiro voiced his support for Dr Soria at the annual congress of the Spanish diabetes society, held in Ca diz earlier this month. Dr Soria has said he will be forced to continue his work abroad, in "an undisclosed country", according to statements made to El Pais. Some 2,000 cadaveric pancreases become available in the US every year, while there are about one million type-1 diabetes patients in the US alone, according to the New York-based Juvenile Diabetes Research Foundation.
You may also be interested in...
Pharma manufacturing is operating well below normal levels in India, disrupted by labor absenteeism and supply chain issues amid the ongoing lock-down in the country, though the government is actively engaged in addressing bottlenecks. A speedy recovery is vital not just for domestic supplies.
Moderna is pursuing a single-antigen strategy even though some of its mRNA vaccines have included multiple antigens; the SARS-CoV-2 spike protein likely provides the best antigen for developing immunity against the virus.
Latest warnings also include second and third businesses in US cannabidiol and hemp sector found making unlawful claims for treating and preventing COVID-19. Four of five firms warned apparently responded by removing violative claims from websites and social media posts.